Open access · US-GOV via ClinicalTrials.gov Clinical trial

Effect of Sarcopenia on the Occurrence of Toxicity Related to Anti-cancer Treatments. Prospective Cohort Study

Authors not listed

Centre Hospitalier Metropole Savoie · 2024

Dysbiosis Human Randomized controlled trial Cohort study

Abstract

The goal of this clinical trial is to learn about the effect of sarcopenic status on the occurrence of treatment-related toxicity during the first course of anti-cancer treatment in several types of cancers. The main question it aims to answer is : Is sarcopenia a predictive marker for the occurrence of toxicity in the initial phase of cancer treatment? The evaluation will focus on the body composition of the participants, assessed by impedancemetry, and on their muscular performance by standardized physical tests.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: ClinicalTrials.gov
Canonical: link ↗
Fetched: 2026-07-02 MST

Cite this

APA

Anonymous. (2024). Effect of Sarcopenia on the Occurrence of Toxicity Related to Anti-cancer Treatments. Prospective Cohort Study. <em>Centre Hospitalier Metropole Savoie</em>. https://clinicaltrials.gov/study/NCT06274268

Vancouver

Anonymous. Effect of Sarcopenia on the Occurrence of Toxicity Related to Anti-cancer Treatments. Prospective Cohort Study. Centre Hospitalier Metropole Savoie. 2024.

BibTeX

@misc{anon2024Effect, title = {Effect of Sarcopenia on the Occurrence of Toxicity Related to Anti-cancer Treatments. Prospective Cohort Study}, author = {Anonymous}, journal = {Centre Hospitalier Metropole Savoie}, year = {2024}, }